CN105147874A - Traditional Chinese medicinal composition for treating verruca plana - Google Patents
Traditional Chinese medicinal composition for treating verruca plana Download PDFInfo
- Publication number
- CN105147874A CN105147874A CN201510425246.8A CN201510425246A CN105147874A CN 105147874 A CN105147874 A CN 105147874A CN 201510425246 A CN201510425246 A CN 201510425246A CN 105147874 A CN105147874 A CN 105147874A
- Authority
- CN
- China
- Prior art keywords
- herba
- traditional chinese
- folium
- verruca plana
- herb
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicinal composition for treating verruca plana. Verruca plana is called 'flat wart' in the traditional Chinese medical science, and is caused by external wind heat and damp toxin which attack the skin and protrude on the body surface, or liver Qi stagnation, blood and Qi disharmony, and Qi stagnation and blood clotting, which blocks the skin. Therefore, according to the invention, the traditional Chinese medicines including herb of thickrostrate begonia, acuminate violet leaf, prostrate wedelia herb, herb of cavalerie mosla, common lantana leaf or branchlet, betel pepper leaves, roxburgh peristrophe herb, hibiscus rosa-sinensis flower, radix saposhnikoviae and safflower carthamus are selected and prepared into a decoction; the clinical test proves that the effective rate of a treatment group achieves 96.5%, which is obviously superior to 75.6% of a control group, and the curative effect is significant.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, particularly relate to a kind of Chinese medicine composition for the treatment of verruca plana
Background technology
Verruca plana is a kind of viral infection dermatoses common clinically, is mainly in teenager, also known as flat wart.Be apt to occur in face, the back of the hand or forearm, mostly suddenly occur.Verruca plana causes spinous layer and granular layer keratinocyte hypertrophy by human papillomavirus's (HPV-3 type), vacuolation causes local cutin to form the increase of increase on cell quantity and volume, in a kind of neoplasm that skin surface is formed, its generation is closely related with the immunologic function of body.A lot, as application antiviral drugs, immunoregulation medicament, physics and chemistry therapy etc., wherein naturopathy and chemotherapy erious adverse reaction, as shortcomings such as local pain, cicatrization, pigmentation time length for the medicine of current treatment and method.Application antiviral drugs, immunoregulation medicament, easily bring side effect to patient, and weak curative effect.Patient is made to be reluctant to accept.Inventor starts with from the angle of the traditional Chinese medical science, according to the endogenous cause of ill that positive QI-insufficiency is morbidity, experience the exopathogenic factor that Shi Re Bing Pian is morbidity, after the empty or serious disease prolonged illness of body, deficiency of both QI and blood, the pathogeny that wind heat poison is in an opponent's defence evil and attack, develop a kind of with heat-clearing and toxic substances removing, blood stasis dispelling of dispeling the wind is the Chinese medicine preparation of principle, through clinical trial, curative effect is better, and side effect is little.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of verruca plana.Motherland's medical science is referred to as " verruca plana ", is due to affection due to external wind and heat noxious dampness, and invasion and attack skin, dashes forward in body surface, or because of stagnation of QI due to depression of the liver, vim and vigour are got along well, and qi stagnation hemagglutination, hinders and form in skin.
The object of the invention is to be achieved through the following technical solutions, the Chinese medicine composition of this treatment verruca plana is made up of the Chinese medicine of following weight portion: Herba Begoniae Crassirostris 18-22g, Folium Violae Acuminatae 18-22g, Herba Wedeliae Prostratae 12-18g, Herba Moslae Cavaleriei 8-12g, Folium Lantanae Camarae 8-12g, Folium piperis betlis 8-12g, Herba Peristrophis Roxburghianae 8-12g, Flos Hibisci Rosae-Sinensis 4-8g, Radix Saposhnikoviae 4-8g, Flos Carthami 4-8g.
Preferred: Herba Begoniae Crassirostris 20g, Folium Violae Acuminatae 20g, Herba Wedeliae Prostratae 15g, Herba Moslae Cavaleriei 10g, Folium Lantanae Camarae 10g, Folium piperis betlis 10g, Herba Peristrophis Roxburghianae 10g, Flos Hibisci Rosae-Sinensis 6g, Radix Saposhnikoviae 6g, Flos Carthami 6g.
Above-mentioned raw material of Chinese medicine is traditionally made decoction.
Herba Begoniae Crassirostris, Folium Violae Acuminatae, Herba Wedeliae Prostratae in side: heat-clearing and toxic substances removing, reducing swelling and alleviating pain; Herba Moslae Cavaleriei: dispelling wind for relieving itching, counteracting toxic substances, the skin ulcer that disappears swell; Folium Lantanae Camarae: dispelling wind for relieving itching, subduing swelling and detoxicating; Folium piperis betlis: dispeiling pathogenic wind and removing dampness, killing parasites for relieving itching; Herba Peristrophis Roxburghianae: antiinflammatory, cough-relieving, hemostasis; Flos Hibisci Rosae-Sinensis: removing heat-phlegm, removing heat from blood, removing toxic substances; Radix Saposhnikoviae, Flos Carthami: blood circulation promoting and blood stasis dispelling.
Clinical data
1, physical data: verruca plana patient 95 example choosing my section's outpatient clinic 1 ~ October in 2010, is divided into treatment group and matched group at random.Treatment group 55 example, male 13 example, women 42 example; 17 ~ 54 years old age, year mean age (26.50 ± 7.05); The course of disease 4 ~ 82 months not etc., individual month of average course of disease (41.55 ± 3.28).Matched group 40 example, male 10 example, women 30 example; 16 ~ 55 years old age, year mean age (24.35 ± 8.23); The course of disease 3 ~ 80 months not etc., individual month of average course of disease (41.65 ± 3.71).Patient age, sex, the equal not statistically significant of course of disease comparing difference between two groups.
2, case inclusion criteria: the verruca plana patient that 1. clinical diagnosis of 16 ~ 60 years old age is clear and definite, male or female; 2. do not take or external antiviral drugs in 1 week; 3. do not adopt in first quarter moon freezing, fulgerize, the physiotherapy such as laser.
3,3, exclusion standard: 1. have allergies to test drug; 2. severe cardiac, liver, nephropathy or general serious disease is had; 3. other drug test was participated in 3 months; 4. Pregnant and lactant women.
4, Therapeutic Method: the oral Chinese medicine composition of the present invention for the treatment of group: Herba Begoniae Crassirostris 20g, Folium Violae Acuminatae 20g, Herba Wedeliae Prostratae 15g, Herba Moslae Cavaleriei 10g, Folium Lantanae Camarae 10g, Folium piperis betlis 10g, Herba Peristrophis Roxburghianae 10g, Flos Hibisci Rosae-Sinensis 6g, Radix Saposhnikoviae 6g, Flos Carthami 6g; every agent decocting makes decoction 2 times; be condensed into 90ml; each serving with 30ml, every day 3 times.Matched group: dipyridamole tablet 25mg, cimetidine capsule 0.2g, oral, every day 3 times.Taking all continuously for two groups 3 weeks is a course for the treatment of, terminates rear statistics curative effect the course for the treatment of.
5, curative effect determinate standard: recovery from illness: skin lesion all disappears; Effective: skin lesion disappears or flattens more than 75%; Effective: skin lesion disappears or flattens more than 50%; Invalid: skin lesion disappears or flattens less than 50%.Effective percentage=(recovery from illness number of cases+effective number of cases+effectively number of cases)/total case load × 100%
6, result efficacy analysis: in therapeutic process, treatment group patient is mostly when medication 1 ~ 2 week, and first occur that skin lesion color is thin out, skin lesion flattens, and occurs without new skin lesion of sending out.After treating a course for the treatment of, treatment group effective percentage reaches 96.5%, and the effective percentage of matched group is only 75.6%.Through statistical analysis, the difference between two groups has statistical significance.
7, untoward reaction: treatment group has no obvious adverse reaction.There is menostaxis in the routine patient of matched group 2, supposition may be relevant with oral cimetidine.
Detailed description of the invention
Embodiment one: take Herba Begoniae Crassirostris 18g, Folium Violae Acuminatae 18g, Herba Wedeliae Prostratae 12g, Herba Moslae Cavaleriei 8g, Folium Lantanae Camarae 8g, Folium piperis betlis 8g, Herba Peristrophis Roxburghianae 8g, Flos Hibisci Rosae-Sinensis 4g, Radix Saposhnikoviae 4g, Flos Carthami 4g; every agent decocting makes decoction 2 times; be condensed into 90ml; each serving with 30ml; every day 3 times, taking continuously 3 weeks is a course for the treatment of.
Embodiment two: take Herba Begoniae Crassirostris 20g, Folium Violae Acuminatae 20g, Herba Wedeliae Prostratae 15g, Herba Moslae Cavaleriei 10g, Folium Lantanae Camarae 10g, Folium piperis betlis 10g, Herba Peristrophis Roxburghianae 10g, Flos Hibisci Rosae-Sinensis 6g, Radix Saposhnikoviae 6g, Flos Carthami 6g, preparation method is with embodiment one.
Embodiment three: take Herba Begoniae Crassirostris 22g, Folium Violae Acuminatae 22g, Herba Wedeliae Prostratae 18g, Herba Moslae Cavaleriei 12g, Folium Lantanae Camarae 12g, Folium piperis betlis 12g, Herba Peristrophis Roxburghianae 12g, Flos Hibisci Rosae-Sinensis 8g, Radix Saposhnikoviae 8g, Flos Carthami 8g, preparation method is with embodiment one.
Claims (2)
1. treat a Chinese medicine composition for verruca plana, it is characterized in that this Chinese medicine composition is made up of the Chinese medicine of following weight portion: Herba Begoniae Crassirostris 18-22g, Folium Violae Acuminatae 18-22g, Herba Wedeliae Prostratae 12-18g, Herba Moslae Cavaleriei 8-12g, Folium Lantanae Camarae 8-12g, Folium piperis betlis 8-12g, Herba Peristrophis Roxburghianae 8-12g, Flos Hibisci Rosae-Sinensis 4-8g, Radix Saposhnikoviae 4-8g, Flos Carthami 4-8g.
2. a kind of Chinese medicine composition for the treatment of verruca plana as claimed in claim 1, is characterized in that this Chinese medicine composition is made up of the Chinese medicine of following weight portion: Herba Begoniae Crassirostris 20g, Folium Violae Acuminatae 20g, Herba Wedeliae Prostratae 15g, Herba Moslae Cavaleriei 10g, Folium Lantanae Camarae 10g, Folium piperis betlis 10g, Herba Peristrophis Roxburghianae 10g, Flos Hibisci Rosae-Sinensis 6g, Radix Saposhnikoviae 6g, Flos Carthami 6g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510425246.8A CN105147874A (en) | 2015-07-14 | 2015-07-14 | Traditional Chinese medicinal composition for treating verruca plana |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510425246.8A CN105147874A (en) | 2015-07-14 | 2015-07-14 | Traditional Chinese medicinal composition for treating verruca plana |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105147874A true CN105147874A (en) | 2015-12-16 |
Family
ID=54789146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510425246.8A Withdrawn CN105147874A (en) | 2015-07-14 | 2015-07-14 | Traditional Chinese medicinal composition for treating verruca plana |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105147874A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102228627A (en) * | 2011-06-16 | 2011-11-02 | 裴有刚 | Medicament for treating flat wart |
CN102688393A (en) * | 2012-05-08 | 2012-09-26 | 安徽智远生物科技有限公司 | Traditional Chinese medicine for treating verruca plana and preparation method thereof |
CN102716421A (en) * | 2012-06-21 | 2012-10-10 | 中国人民解放军第三军医大学第一附属医院 | Chinese medicine oral liquid for treating flat wart and preparation method of Chinese medicine oral liquid |
CN103083480A (en) * | 2011-10-27 | 2013-05-08 | 路文鹏 | Preparation method for traditional Chinese medicine prescription capable of treating verruca plana |
CN104645177A (en) * | 2015-03-26 | 2015-05-27 | 韩艳芬 | Traditional Chinese medicine composition for treating flat wart |
-
2015
- 2015-07-14 CN CN201510425246.8A patent/CN105147874A/en not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102228627A (en) * | 2011-06-16 | 2011-11-02 | 裴有刚 | Medicament for treating flat wart |
CN103083480A (en) * | 2011-10-27 | 2013-05-08 | 路文鹏 | Preparation method for traditional Chinese medicine prescription capable of treating verruca plana |
CN102688393A (en) * | 2012-05-08 | 2012-09-26 | 安徽智远生物科技有限公司 | Traditional Chinese medicine for treating verruca plana and preparation method thereof |
CN102716421A (en) * | 2012-06-21 | 2012-10-10 | 中国人民解放军第三军医大学第一附属医院 | Chinese medicine oral liquid for treating flat wart and preparation method of Chinese medicine oral liquid |
CN104645177A (en) * | 2015-03-26 | 2015-05-27 | 韩艳芬 | Traditional Chinese medicine composition for treating flat wart |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005110431A1 (en) | Herbal product containing glucosamine | |
CN101011544A (en) | Gout rapid recovery pill(capsule) and preparation technique thereof | |
CN103599492B (en) | A kind of medicine of Acne treatment | |
CN1951485A (en) | An antivirus medicament | |
CN1709302A (en) | Chinese medicine formulation for treating chronic pelvic inflammation and its preparing method | |
CN102552520B (en) | Blood circulation-promoting and pain-stopping medicament and preparation process and application thereof | |
CN106039109A (en) | Traditional Chinese medicinal liquor for preventing and treating cold dampness accumulation pattern rheumatoid arthritis | |
CN102671046B (en) | Chinese medicament for treating chronic appendicitis | |
CN102342985A (en) | Chinese medicinal prescription for treating chloasma | |
CN104337989A (en) | Traditional Chinese medicine composition containing centipeda minima and frankincense for treating gout | |
CN103908600A (en) | Externally-applied medicine for treating rheumatoid arthritis damp-heat blockage symptom as well as preparation method and administration method thereof | |
CN103211946B (en) | Traditional Chinese medicine for treating gastric ulcer and duodenal ulcer | |
CN105147874A (en) | Traditional Chinese medicinal composition for treating verruca plana | |
CN103638336A (en) | Full rhizoma gastrodiae tablet | |
CN103566185B (en) | Chinese medicine composition for the treatment of tinea manus and pedis and preparation method thereof | |
CN102764325B (en) | Chinese medicinal composition for dispelling rheumatism and relieving pain | |
CN102133274A (en) | Chinese medicinal composition | |
CN105582243A (en) | Traditional Chinese medicine composition for treating solar dermatitis | |
CN1899401B (en) | Three ingredient body comfort liquid | |
CN101224295A (en) | Chinese traditional medicine compounds for treating digestive system tumor and preparing method thereof | |
CN1709298A (en) | Chinese medicine formulation for treating chronic prostatitis and its preparing method | |
CN105343741A (en) | Traditional Chinese medicine for treating thyroid tumor and preparation method of traditional Chinese medicine | |
CN1843493A (en) | Externally applied medicine for relieving pain and preparation method thereof | |
CN104825756A (en) | Traditional Chinese medicine composition for treating chronic renal failure | |
CN105267650A (en) | Traditional Chinese medicine for treating hypertension |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20151216 |
|
WW01 | Invention patent application withdrawn after publication |